Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Lung Cancer Diagnosis and Therapeutics industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Roche
Eisai
AbbVie
GSK
Bristol-Myers Squibb
Eli Lilly
Bayer
Pharmacyclics
Daiichi Sankyo
Sanofi
Pfizer
AstraZeneca
ArQule
Celgene
Boehringer Ingelheim
By Type:
Small Cell Lung Cancer
Non-Small Cell Lung Cancer
By Application:
Hospitals
Cancer Research Centers
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Lung Cancer Diagnosis and Therapeutics Market Overview 2018-2029
-
1.1 China Lung Cancer Diagnosis and Therapeutics Industry Development Overview
-
1.2 China Lung Cancer Diagnosis and Therapeutics Industry Development History
-
1.3 China Lung Cancer Diagnosis and Therapeutics Industry Market Size (2018-2029)
-
1.4 China Lung Cancer Diagnosis and Therapeutics Market Analysis by Type from Production Side
-
1.4.1 China Lung Cancer Diagnosis and Therapeutics Production Volume, Production Value and Growth Rate of Small Cell Lung Cancer (2018-2029)
-
1.4.2 China Lung Cancer Diagnosis and Therapeutics Production Volume, Production Value and Growth Rate of Non-Small Cell Lung Cancer (2018-2029)
-
1.5 China Lung Cancer Diagnosis and Therapeutics Market Analysis by Application from Consumption End
-
1.5.1 China Lung Cancer Diagnosis and Therapeutics Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
1.5.2 China Lung Cancer Diagnosis and Therapeutics Sales Volume, Sales Value and Growth Rate of Cancer Research Centers (2018-2029)
-
1.6 China Lung Cancer Diagnosis and Therapeutics Market Analysis by Region
-
1.6.1 North China Lung Cancer Diagnosis and Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Lung Cancer Diagnosis and Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Lung Cancer Diagnosis and Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Lung Cancer Diagnosis and Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Lung Cancer Diagnosis and Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Lung Cancer Diagnosis and Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Lung Cancer Diagnosis and Therapeutics Market Size and Growth Rate from 2018-2029
Chapter 2 China Lung Cancer Diagnosis and Therapeutics Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Lung Cancer Diagnosis and Therapeutics Market Status and Competition at home and abroad in 2023
-
2.2.2 China Lung Cancer Diagnosis and Therapeutics Market Status and Competition Analysis in 2023
-
2.2.3 China Lung Cancer Diagnosis and Therapeutics Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Lung Cancer Diagnosis and Therapeutics Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Lung Cancer Diagnosis and Therapeutics Industry Development
Chapter 3 Lung Cancer Diagnosis and TherapeuticsIndustry Chain Analysis
-
3.1 Lung Cancer Diagnosis and Therapeutics Industry Chain
-
3.2 Lung Cancer Diagnosis and Therapeutics Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Lung Cancer Diagnosis and Therapeutics Market
-
3.3 Lung Cancer Diagnosis and Therapeutics Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Lung Cancer Diagnosis and Therapeutics Market
Chapter 4 China Lung Cancer Diagnosis and Therapeutics Market, by Type
-
4.1 China Lung Cancer Diagnosis and Therapeutics Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Lung Cancer Diagnosis and Therapeutics Total Production Volume and Growth Rate from Production Side
-
4.5 China Lung Cancer Diagnosis and Therapeutics Production Volume and Growth Rate, by Type
-
4.5.1 China Lung Cancer Diagnosis and Therapeutics Production Volume and Growth Rate of Small Cell Lung Cancer
-
4.5.2 China Lung Cancer Diagnosis and Therapeutics Production Volume and Growth Rate of Non-Small Cell Lung Cancer
Chapter 5 China Lung Cancer Diagnosis and Therapeutics Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Lung Cancer Diagnosis and Therapeutics Total Market Size and Growth Rate from Consumption End
-
5.5 China Lung Cancer Diagnosis and Therapeutics Market Size and Growth Rate, by Application
-
5.5.1 China Lung Cancer Diagnosis and Therapeutics Market Size and Growth Rate of Hospitals
-
5.5.2 China Lung Cancer Diagnosis and Therapeutics Market Size and Growth Rate of Cancer Research Centers
Chapter 6 China Lung Cancer Diagnosis and Therapeutics Market, by Region
-
6.1 China Lung Cancer Diagnosis and Therapeutics Production Volume and Production Value, by Region
-
6.2 China Lung Cancer Diagnosis and Therapeutics Sales Volume and Sales Value, by Region
Chapter 7 North China Lung Cancer Diagnosis and Therapeutics Market Analysis
-
7.1 North China Lung Cancer Diagnosis and Therapeutics Market, by Type
-
7.2 North China Lung Cancer Diagnosis and Therapeutics Market, by Application
Chapter 8 Central China Lung Cancer Diagnosis and Therapeutics Market Analysis
-
8.1 Central China Lung Cancer Diagnosis and Therapeutics Market, by Type
-
8.2 Central China Lung Cancer Diagnosis and Therapeutics Market, by Application
Chapter 9 South China Lung Cancer Diagnosis and Therapeutics Market Analysis
-
9.1 South China Lung Cancer Diagnosis and Therapeutics Market, by Type
-
9.2 South China Lung Cancer Diagnosis and Therapeutics Market, by Application
Chapter 10 East China Lung Cancer Diagnosis and Therapeutics Market Analysis
-
10.1 East China Lung Cancer Diagnosis and Therapeutics Market, by Type
-
10.2 East China Lung Cancer Diagnosis and Therapeutics Market, by Application
Chapter 11 Northeast China Lung Cancer Diagnosis and Therapeutics Market Analysis
-
11.1 Northeast China Lung Cancer Diagnosis and Therapeutics Market, by Type
-
11.2 Northeast China Lung Cancer Diagnosis and Therapeutics Market, by Application
Chapter 12 Southwest China Lung Cancer Diagnosis and Therapeutics Market Analysis
-
12.1 Southwest China Lung Cancer Diagnosis and Therapeutics Market, by Type
-
12.2 Southwest China Lung Cancer Diagnosis and Therapeutics Market, by Application
Chapter 13 Northwest China Lung Cancer Diagnosis and Therapeutics Market Analysis
-
13.1 Northwest China Lung Cancer Diagnosis and Therapeutics Market, by Type
-
13.2 Northwest China Lung Cancer Diagnosis and Therapeutics Market, by Application
Chapter 14 Company Profiles
-
14.1 Roche
-
14.1.1 Roche Company Profile
-
14.1.2 Roche Lung Cancer Diagnosis and Therapeutics Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Eisai
-
14.2.1 Eisai Company Profile
-
14.2.2 Eisai Lung Cancer Diagnosis and Therapeutics Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 AbbVie
-
14.3.1 AbbVie Company Profile
-
14.3.2 AbbVie Lung Cancer Diagnosis and Therapeutics Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 GSK
-
14.4.1 GSK Company Profile
-
14.4.2 GSK Lung Cancer Diagnosis and Therapeutics Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Bristol-Myers Squibb
-
14.5.1 Bristol-Myers Squibb Company Profile
-
14.5.2 Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Eli Lilly
-
14.6.1 Eli Lilly Company Profile
-
14.6.2 Eli Lilly Lung Cancer Diagnosis and Therapeutics Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Bayer
-
14.7.1 Bayer Company Profile
-
14.7.2 Bayer Lung Cancer Diagnosis and Therapeutics Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Pharmacyclics
-
14.8.1 Pharmacyclics Company Profile
-
14.8.2 Pharmacyclics Lung Cancer Diagnosis and Therapeutics Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Daiichi Sankyo
-
14.9.1 Daiichi Sankyo Company Profile
-
14.9.2 Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Sanofi
-
14.10.1 Sanofi Company Profile
-
14.10.2 Sanofi Lung Cancer Diagnosis and Therapeutics Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Pfizer
-
14.11.1 Pfizer Company Profile
-
14.11.2 Pfizer Lung Cancer Diagnosis and Therapeutics Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 AstraZeneca
-
14.12.1 AstraZeneca Company Profile
-
14.12.2 AstraZeneca Lung Cancer Diagnosis and Therapeutics Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 ArQule
-
14.13.1 ArQule Company Profile
-
14.13.2 ArQule Lung Cancer Diagnosis and Therapeutics Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Celgene
-
14.14.1 Celgene Company Profile
-
14.14.2 Celgene Lung Cancer Diagnosis and Therapeutics Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Boehringer Ingelheim
-
14.15.1 Boehringer Ingelheim Company Profile
-
14.15.2 Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Market Performance
-
14.15.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Lung Cancer Diagnosis and Therapeutics Industry Research Conclusions
-
15.2 Lung Cancer Diagnosis and Therapeutics Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Lung Cancer Diagnosis and Therapeutics Industry Market Size (2018-2029)
-
Figure China Lung Cancer Diagnosis and Therapeutics Production Volume, Production Value and Growth Rate of Small Cell Lung Cancer (2018-2029)
-
Figure China Lung Cancer Diagnosis and Therapeutics Production Volume, Production Value and Growth Rate of Non-Small Cell Lung Cancer (2018-2029)
-
Figure China Lung Cancer Diagnosis and Therapeutics Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
Figure China Lung Cancer Diagnosis and Therapeutics Sales Volume, Sales Value and Growth Rate of Cancer Research Centers (2018-2029)
-
Figure North China Lung Cancer Diagnosis and Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Central China Lung Cancer Diagnosis and Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure South China Lung Cancer Diagnosis and Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure East China Lung Cancer Diagnosis and Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Lung Cancer Diagnosis and Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Lung Cancer Diagnosis and Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Lung Cancer Diagnosis and Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Lung Cancer Diagnosis and Therapeutics Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Lung Cancer Diagnosis and Therapeutics Market Share by Type in 2018
-
Figure China Lung Cancer Diagnosis and Therapeutics Market Share by Type in 2023
-
Figure China Lung Cancer Diagnosis and Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Lung Cancer Diagnosis and Therapeutics Production Volume and Growth Rate of Small Cell Lung Cancer (2018-2023)
-
Figure China Lung Cancer Diagnosis and Therapeutics Production Volume and Growth Rate of Non-Small Cell Lung Cancer (2018-2023)
-
Figure China Lung Cancer Diagnosis and Therapeutics Market Share by Application in 2018
-
Figure China Lung Cancer Diagnosis and Therapeutics Market Share by Application in 2023
-
Figure China Lung Cancer Diagnosis and Therapeutics Total Market Size and Growth Rate from Consumption End
-
Figure China Lung Cancer Diagnosis and Therapeutics Market Size and Growth Rate of Hospitals (2018-2023)
-
Figure China Lung Cancer Diagnosis and Therapeutics Market Size and Growth Rate of Cancer Research Centers (2018-2023)
-
Table China Lung Cancer Diagnosis and Therapeutics Production Volume by Region (2018-2023)
-
Table China Lung Cancer Diagnosis and Therapeutics Production Volume Share by Region (2018-2023)
-
Figure China Lung Cancer Diagnosis and Therapeutics Production Volume Share by Region (2018-2023)
-
Table China Lung Cancer Diagnosis and Therapeutics Production Value by Region (2018-2023)
-
Table China Lung Cancer Diagnosis and Therapeutics Production Value Share by Region (2018-2023)
-
Figure China Lung Cancer Diagnosis and Therapeutics Production Value Share by Region (2018-2023)
-
Table China Lung Cancer Diagnosis and Therapeutics Sales Volume by Region (2018-2023)
-
Table China Lung Cancer Diagnosis and Therapeutics Sales Volume Share by Region (2018-2023)
-
Figure China Lung Cancer Diagnosis and Therapeutics Sales Volume Share by Region (2018-2023)
-
Table China Lung Cancer Diagnosis and Therapeutics Sales Value by Region (2018-2023)
-
Table China Lung Cancer Diagnosis and Therapeutics Sales Value Share by Region (2018-2023)
-
Figure China Lung Cancer Diagnosis and Therapeutics Sales Value Share by Region (2018-2023)
-
Table North China Lung Cancer Diagnosis and Therapeutics Production Volume by Type (2018-2023)
-
Table North China Lung Cancer Diagnosis and Therapeutics Production Volume Share by Type (2018-2023)
-
Figure North China Lung Cancer Diagnosis and Therapeutics Production Volume Share by Type (2018-2023)
-
Table North China Lung Cancer Diagnosis and Therapeutics Sales Volume by Application (2018-2023)
-
Table North China Lung Cancer Diagnosis and Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure North China Lung Cancer Diagnosis and Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Central China Lung Cancer Diagnosis and Therapeutics Production Volume by Type (2018-2023)
-
Table Central China Lung Cancer Diagnosis and Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Central China Lung Cancer Diagnosis and Therapeutics Production Volume Share by Type (2018-2023)
-
Table Central China Lung Cancer Diagnosis and Therapeutics Sales Volume by Application (2018-2023)
-
Table Central China Lung Cancer Diagnosis and Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Central China Lung Cancer Diagnosis and Therapeutics Sales Volume Share by Application (2018-2023)
-
Table South China Lung Cancer Diagnosis and Therapeutics Production Volume by Type (2018-2023)
-
Table South China Lung Cancer Diagnosis and Therapeutics Production Volume Share by Type (2018-2023)
-
Figure South China Lung Cancer Diagnosis and Therapeutics Production Volume Share by Type (2018-2023)
-
Table South China Lung Cancer Diagnosis and Therapeutics Sales Volume by Application (2018-2023)
-
Table South China Lung Cancer Diagnosis and Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure South China Lung Cancer Diagnosis and Therapeutics Sales Volume Share by Application (2018-2023)
-
Table East China Lung Cancer Diagnosis and Therapeutics Production Volume by Type (2018-2023)
-
Table East China Lung Cancer Diagnosis and Therapeutics Production Volume Share by Type (2018-2023)
-
Figure East China Lung Cancer Diagnosis and Therapeutics Production Volume Share by Type (2018-2023)
-
Table East China Lung Cancer Diagnosis and Therapeutics Sales Volume by Application (2018-2023)
-
Table East China Lung Cancer Diagnosis and Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure East China Lung Cancer Diagnosis and Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Northeast China Lung Cancer Diagnosis and Therapeutics Production Volume by Type (2018-2023)
-
Table Northeast China Lung Cancer Diagnosis and Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Northeast China Lung Cancer Diagnosis and Therapeutics Production Volume Share by Type (2018-2023)
-
Table Northeast China Lung Cancer Diagnosis and Therapeutics Sales Volume by Application (2018-2023)
-
Table Northeast China Lung Cancer Diagnosis and Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Lung Cancer Diagnosis and Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Southwest China Lung Cancer Diagnosis and Therapeutics Production Volume by Type (2018-2023)
-
Table Southwest China Lung Cancer Diagnosis and Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Southwest China Lung Cancer Diagnosis and Therapeutics Production Volume Share by Type (2018-2023)
-
Table Southwest China Lung Cancer Diagnosis and Therapeutics Sales Volume by Application (2018-2023)
-
Table Southwest China Lung Cancer Diagnosis and Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Lung Cancer Diagnosis and Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Northwest China Lung Cancer Diagnosis and Therapeutics Production Volume by Type (2018-2023)
-
Table Northwest China Lung Cancer Diagnosis and Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Northwest China Lung Cancer Diagnosis and Therapeutics Production Volume Share by Type (2018-2023)
-
Table Northwest China Lung Cancer Diagnosis and Therapeutics Sales Volume by Application (2018-2023)
-
Table Northwest China Lung Cancer Diagnosis and Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Lung Cancer Diagnosis and Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Roche Company Profile
-
Table Roche Lung Cancer Diagnosis and Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Eisai Company Profile
-
Table Eisai Lung Cancer Diagnosis and Therapeutics Revenue, Price and Gross (2018-2023)
-
Table AbbVie Company Profile
-
Table AbbVie Lung Cancer Diagnosis and Therapeutics Revenue, Price and Gross (2018-2023)
-
Table GSK Company Profile
-
Table GSK Lung Cancer Diagnosis and Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Company Profile
-
Table Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly Company Profile
-
Table Eli Lilly Lung Cancer Diagnosis and Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Bayer Company Profile
-
Table Bayer Lung Cancer Diagnosis and Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Pharmacyclics Company Profile
-
Table Pharmacyclics Lung Cancer Diagnosis and Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Daiichi Sankyo Company Profile
-
Table Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Lung Cancer Diagnosis and Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Lung Cancer Diagnosis and Therapeutics Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Lung Cancer Diagnosis and Therapeutics Revenue, Price and Gross (2018-2023)
-
Table ArQule Company Profile
-
Table ArQule Lung Cancer Diagnosis and Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Celgene Company Profile
-
Table Celgene Lung Cancer Diagnosis and Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingelheim Company Profile
-
Table Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Revenue, Price and Gross (2018-2023)
-
